Advertisement
Screener

RadNet, Inc. (RDNT) Current Ratio

RadNet, Inc. (RDNT) Current Ratio

  • Current ratio · latest quarter: Value 1.48×; Formula and calculation Current assets / current liabilities..

Current ratio

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Current ratio · latest quarter1.48×Current assets / current liabilities.

$1.04B ÷ $697.82M ≈ 1.48×

Calculation inputs

InputAmount with unitRaw financial data
Current assets1.04B USDAssets, Current
Current obligations697.82M USDLiabilities, Current
Cash and equivalents726.27M USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)
Customer receivables241.84M USDAccounts Receivable, after Allowance for Credit Loss, Current
Inventory(m)
Payables(m)Accounts Payable, Current
Borrowing debt due within one year30.67M USDLong-term Debt, Current Maturities

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingCurrent assets (USD)Current obligations (USD)Cash and equivalents (USD)Short-term securities (USD)Customer receivables (USD)Inventory (USD)Payables (USD)Borrowing debt due within one year (USD)Current ratio
2026-06-30$1.04B$697.82M$726.27M(m)$241.84M(m)(m)$30.67M1.48×
2026-03-31$740.77M$635.63M$455.34M(m)$209.09M(m)(m)$26.51M1.17×
2025-12-31$1.03B$586.76M$767.22M(m)$200.32M(m)(m)$25.42M1.76×
2025-09-30$1.08B$574.91M$804.72M(m)$210.55M(m)(m)$25.45M1.87×
2025-06-30$1.09B$546.21M$833.15M(m)$199.99M(m)(m)$25.48M2.00×
2025-03-31$1.02B$505.40M$717.32M(m)$200.13M(m)(m)$24.68M2.01×
2024-12-31$1.02B$479.71M$740.02M(m)$185.82M(m)$96.45M$24.69M2.12×
2024-09-30$1.02B$470.13M$748.92M(m)$199.08M(m)(m)$23.38M2.16×
2024-06-30$1.00B$474.20M$741.68M(m)$195.29M(m)(m)$24.21M2.12×
2024-03-31$795.83M$427.89M$526.98M(m)$189.57M(m)(m)$20.20M1.86×
2023-12-31$579.28M$437.45M$342.57M(m)$163.71M(m)$122.89M$17.97M1.32×
2023-09-30$578.67M$407.08M$337.88M(m)$167.74M(m)(m)$16.04M1.42×
2023-06-30$602.69M$434.23M$356.65M(m)$174.48M(m)(m)$15.99M1.39×
2023-03-31$342.69M$407.14M$90.84M(m)$176.35M(m)(m)$15.94M0.84×
2022-12-31$367.18M$466.72M$127.83M(m)$166.36M(m)$102.68M$12.40M0.79×
2022-09-30$324.50M$409.22M$95.01M(m)$172.51M(m)(m)$10.79M0.79×
2022-06-30$319.10M$404.52M$99.17M(m)$166.39M(m)(m)$11.16M0.79×
2022-03-31$288.70M$381.30M$70.71M(m)$159.72M(m)(m)$11.16M0.76×
2021-12-31$324.26M$374.78M$134.61M(m)$135.06M(m)$86.46M$11.16M0.87×
2021-09-30$340.00M$371.50M$151.25M(m)$152.41M(m)(m)$11.16M0.92×
2021-06-30$334.92M$381.27M$140.85M(m)$157.33M(m)(m)(m)0.88×
2021-03-31$223.00M$402.62M$31.09M(m)$146.66M(m)(m)(m)0.55×
2020-12-31$270.42M$398.11M$102.02M(m)$129.59M(m)$70.07M$39.79M0.68×
2020-09-30$259.06M$373.79M$89.74M(m)$137.41M(m)(m)(m)0.69×
2020-06-30$247.52M$382.39M$84.58M(m)$125.75M(m)(m)(m)0.65×
2020-03-31$280.20M$327.99M$94.28M(m)$144.26M(m)(m)(m)0.85×
2019-12-31$241.17M$327.43M$40.16M(m)$154.76M(m)$64.30M(m)0.74×
2019-09-30$239.72M$309.52M$37.69M(m)$150.75M(m)(m)(m)0.77×
2019-06-30$234.47M$293.25M$30.50M(m)$159.32M(m)(m)(m)0.80×
2019-03-31$216.13M$300.59M$10.43M(m)$156.77M(m)(m)(m)0.72×
2018-12-31$208.69M$239.52M$10.39M(m)$148.92M(m)$68.04M(m)0.87×
2018-09-30$227.02M$203.39M$27.23M(m)$156.40M(m)(m)(m)1.12×
2018-06-30$206.13M$193.97M$16.25M(m)$152.17M(m)(m)(m)1.06×
2018-03-31$230.20M$204.86M$35.04M(m)$161.65M(m)(m)(m)1.12×
2017-12-31$235.35M$191.61M$51.32M(m)$155.52M(m)$28.54M(m)1.23×
2017-09-30$201.56M$156.75M$8.47M(m)$168.59M(m)(m)(m)1.29×
2017-06-30$207.65M$151.80M$12.71M(m)$170.16M(m)(m)(m)1.37×
2017-03-31$208.44M$158.93M$8.29M(m)$169.54M(m)(m)(m)1.31×
2016-12-31$217.91M$155.34M$20.64M(m)$164.21M(m)$40.95M(m)1.40×
2016-09-30$237.68M$152.57M$358.00K(m)$183.23M(m)(m)(m)1.56×
2016-06-30$222.58M$150.09M$433.00K(m)$165.09M(m)(m)(m)1.48×
2016-03-31$237.94M$154.51M$410.00K(m)$177.83M(m)(m)(m)1.54×
2015-12-31$11.47M$1.32M$0.00(m)$5.67M(m)$1.00K(m)8.70×
2015-09-30$256.30M$136.50M$36.05M(m)$159.21M(m)(m)(m)1.88×
2015-06-30$243.39M$128.34M$5.32M(m)$155.96M(m)(m)(m)1.90×
2015-03-31$194.32M$132.66M$154.00K(m)$153.26M(m)(m)(m)1.46×
2014-12-31$13.08M$2.41M$3.00K(m)$7.44M(m)$98.00K(m)5.44×
2014-09-30$197.25M$131.52M$274.00K(m)$155.01M(m)(m)(m)1.50×
2014-06-30$188.32M$127.61M$831.00K(m)$147.02M(m)(m)(m)1.48×
2014-03-31$182.87M$121.48M$291.00K(m)$140.63M(m)(m)(m)1.51×
2013-12-31$12.35M$2.98M$288.00K(m)$8.60M(m)(m)(m)4.14×
2013-09-30$158.22M$111.44M$268.00K(m)$134.26M(m)(m)(m)1.42×
2013-06-30$162.27M$120.44M$251.00K(m)$139.37M(m)(m)(m)1.35×
2013-03-31$164.38M$125.20M$431.00K(m)$134.94M(m)(m)(m)1.31×
2012-12-31$12.10M$3.39M$1.78M(m)$8.60M(m)$839.00K(m)3.57×
2012-09-30$149.27M$117.93M$388.00K(m)$128.64M(m)(m)(m)1.27×
2012-06-30$152.85M$126.44M$234.00K(m)$131.44M(m)(m)(m)1.21×
2012-03-31$155.66M$128.18M$1.83M(m)$133.97M(m)(m)(m)1.21×
2011-12-31$13.17M$6.72M$2.09M(m)$8.33M(m)$873.00K(m)1.96×
2011-09-30$138.59M$109.42M$254.00K(m)$122.04M(m)(m)(m)1.27×
2011-06-30$132.42M$111.93M$178.00K(m)$116.90M(m)(m)(m)1.18×
2010-12-31$111.03M$105.26M$627.00K(m)$96.09M(m)(m)(m)1.05×

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70